Fortress Biotech
FBIO
77 hedge funds and large institutions have $117M invested in Fortress Biotech in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 14 reducing their positions, and 10 closing their positions.
114% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 14
92% more capital invested
Capital invested by funds: $60.6M → $117M (+$56M)
40% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 10
5% more funds holding
Funds holding: 73 → 77 (+4)
0.51% more ownership
Funds ownership: 1.83% → 2.33% (+0.51%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$12.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.47M |
| 3 |
Morgan Stanley
New York
|
+$3.06M |
| 4 |
BlackRock
New York
|
+$1.93M |
| 5 |
Two Sigma Investments
New York
|
+$1.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$1.95M |
| 2 |
FIA
FNY Investment Advisers
New York
|
-$469K |
| 3 |
Jane Street
New York
|
-$326K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$86K |
| 5 |
SG Americas Securities
New York
|
-$85K |
FBIO Hedge Fund Activity: Q3 2020 in Review
77 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q3 2020, worth a combined $117M — up 92% from $60.6M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new FBIO positions and 10 closed out — a net gain of 4 holders — while 30 added to existing stakes and 14 trimmed.
The largest buyer was Nantahala Capital Management, adding an estimated $12.9M. The largest seller was Renaissance Technologies, cutting an estimated $1.95M.
- 77 institutional investors held Fortress Biotech (FBIO) as of Q3 2020, up from 73 in Q2 2020.
- Funds reported $117M of Fortress Biotech stock for Q3 2020, up 92% quarter-over-quarter.
- 14 funds opened new Fortress Biotech positions in Q3 2020 and 10 closed out, a net change of +4 holders.
- The largest Fortress Biotech buyer in Q3 2020 was Nantahala Capital Management, an estimated $12.9M added.
- The largest Fortress Biotech seller in Q3 2020 was Renaissance Technologies, an estimated $1.95M sold.
Based on aggregated 13F filings for Q3 2020.